Related Experiment Video
Updated: Aug 30, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Immune abnormalities induced by human endogenous retroviral peptides: with reference to the pathogenesis of systemic
Toshio Naito1, Hitoshi Ogasawara, Hiroshi Kaneko
1Department of General Medicine, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan.
Abstract:
P15E is a specific sequence among the envelope gene (env)-encoded transmembrane proteins of exogenous and endogenous retroviruses. A synthetic peptide (CKS- 17) that shows homology to this p15E region in several species of retrovirus is known to induce immune abnormalities. In this study, we examined the effect of a synthetic peptide derived from a region of human endogenous retrovirus (HERV) clone 4-1 (lambda4 - 1) similar to sequences of CKS-17 on the induction of systemic lupus erythematosus (SLE)-related immune abnormalities. Our results indicated that this peptide could induce T-cell activation and anergy in normal peripheral blood mononuclear cells, and the peptide could also promote the production of interleukins IL-6 and IL-16. These phenomena are representative immune abnormalities observed in SLE patients. Thus, our findings support the possibility that HERV acts as a pathogen in human SLE.
Insights
Human endogenous retroviruses (HERV) may play a role in systemic lupus erythematosus (SLE). A synthetic HERV peptide induced immune abnormalities similar to those seen in SLE patients, suggesting a potential pathogenic link.
Area of Science:
- Immunology
- Virology
- Genetics
Background:
- P15E is a retroviral transmembrane protein sequence.
- Synthetic peptide CKS-17, homologous to p15E, induces immune abnormalities.
- Human endogenous retroviruses (HERV) are integrated into the human genome.
Purpose of the Study:
- To investigate the effect of a synthetic HERV-derived peptide on immune abnormalities.
- To explore the potential role of HERV in systemic lupus erythematosus (SLE).
Main Methods:
- A synthetic peptide from HERV clone 4-1 (lambda4-1) was used.
- Normal peripheral blood mononuclear cells were treated with the peptide.
- Immune responses, including T-cell activation, anergy, and cytokine production (IL-6, IL-16), were analyzed.
Main Results:
- The HERV-derived peptide induced T-cell activation and anergy.
- The peptide promoted the production of interleukins IL-6 and IL-16.
- These induced immune changes mimic abnormalities observed in SLE patients.
Conclusions:
- The synthetic HERV peptide can induce SLE-related immune abnormalities.
- HERV may function as a pathogen in the development of human SLE.
- Further research is warranted to confirm the role of HERV in SLE pathogenesis.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Mechanisms of Retrovirus-induced Cancers
Inhibitors of Viral Protein Synthesis
Retroviruses
Encephalitis ll: Pathophysiology
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
